Insulet Corp. (PODD) Tops Q2 EPS by 1c, Revenue Guidance Falls Short

Insulet Corp. (NASDAQ: PODD) reported Q2 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $72 million versus the consensus estimate of $72.94 million.

Insulet Corp. sees FY2014 revenue of $290-300 million, versus the consensus of $305.3 million.

Insulet Corp. sees Q3 2014 revenue of $73-77 million, versus the consensus of $78.2 million.

For earnings history and earnings-related data on Insulet Corp. (PODD) click here.

You May Also Be Interested In

• Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Bloom Energy Corporation (NYSE: BE); Erasca, Inc. (NASDAQ: ERAS); and Insulet Corporation (NASDAQ: PODD): Grabar Law Offic
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Reading (RDI) Tops Q2 EPS by 4c